Sponsor
Second Affiliated Hospital of Soochow University
Clinical research sponsor
Clinical trials
31 shownA Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBCNCT06235931 · lead sponsor · 2024-02-01
RECRUITINGEvaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney DiseaseNCT06838416 · lead sponsor · 2023-11-17
RECRUITINGLight Therapy in Parkinson's DiseaseNCT06129942 · lead sponsor · 2021-09-01
RECRUITINGA Study of Dimdazenil in Patients With Parkinson's Disease and InsomniaNCT07714772 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGDPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 DiabetesNCT07241897 · lead sponsor · 2025-12-15
NOT_YET_RECRUITINGThe Impact of Thoracic Paravertebral Nerve Block At Different Positions on Pain Relief in Patients Undergoing Single-Port Thoracoscopic Partial Lung ResectionNCT06789276 · lead sponsor · 2025-01-18
NOT_YET_RECRUITINGClinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's DiseaseNCT07176091 · lead sponsor · 2025-01-01
ENROLLING_BY_INVITATIONA Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.NCT07836140 · lead sponsor · 2024-04-22
COMPLETEDA Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's DiseaseNCT06195124 · lead sponsor · 2023-12-01
UNKNOWNBasic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's DiseaseNCT06236230 · lead sponsor · 2023-11-15
UNKNOWNA Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.NCT06319118 · lead sponsor · 2023-10-01
COMPLETEDA Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung CancerNCT06047860 · lead sponsor · 2023-06-16
UNKNOWNVinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)NCT05603013 · lead sponsor · 2022-10-30
UNKNOWNRepetitive Transcranial Magnetic Stimulation for Musculoskeletal Pain in Patients With Parkinson's DiseaseNCT05537597 · lead sponsor · 2022-10-01
COMPLETEDSelegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's DiseaseNCT04870372 · lead sponsor · 2020-03-01
COMPLETEDthe Efficacy and Safety of Agomelatine in the Patients With Parkinson's DiseaseNCT03977441 · lead sponsor · 2019-07-01
UNKNOWNIdebenone Treatment of Early Parkinson's DiseasesymptomsNCT03727295 · lead sponsor · 2019-01-01
UNKNOWNCombined Diagnosis of CT and Exosome in Early Lung CancerNCT03542253 · lead sponsor · 2018-05-20
UNKNOWNPreoperative and Postoperative ctDNA Comparison in Early Stage Lung CancerNCT03805256 · lead sponsor · 2018-05-14
UNKNOWNA Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease PatientNCT03128450 · lead sponsor · 2017-04-15
UNKNOWNEvaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 DiabetesNCT02900417 · lead sponsor · 2016-09-01
UNKNOWNAI-Enhanced Optimization of Acute Levodopa Challenge TestNCT06949865 · collaborator · 2024-05-28
RECRUITINGEffects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DMNCT07323381 · collaborator · 2025-12-30
NOT_YET_RECRUITINGEfficacy of Henagliflozin for Weight Loss in Obesity Without DiabetesNCT06216340 · collaborator · 2024-02-15
UNKNOWNEfficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseNCT05611372 · collaborator · 2023-01-01
WITHDRAWNHFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese PatientsNCT05526339 · collaborator · 2022-09-01
UNKNOWNAsymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label StudyNCT04616521 · collaborator · 2021-01-01
NOT_YET_RECRUITINGA Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson DiseaseNCT04152655 · collaborator · 2020-01-01
WITHDRAWNAnlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung CancerNCT03766490 · collaborator · 2019-03-30
UNKNOWNA Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's DiseaseNCT04453995 · collaborator · 2019-01-05
UNKNOWNEffect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential TherapyNCT02129985 · collaborator · 2014-02-01
UNKNOWNSponsor roles
lead sponsor21
collaborator10
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.